Malignant Brain Tumors Recruiting Phase 1 Trials for Temozolomide (DB00853)

Also known as: Malignant Brain Tumor

IndicationStatusPhase
DBCOND0050591 (Malignant Brain Tumors)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs